Extended Data Table 2.

Overview of patient cohort for IHC analysis.

No	Disease	Age	Gender	ALT(UlL)	AST(UlL)	Fibrosis	Cirrhosis	Activity
1	Normal	39	M	70	44	0	N/A	N/A
2	Normal	29	F	18	26	0	N/A	N/A
3	Normal	50	F	8	19	0	N/A	N/A
4	Normal	44	M	21	20	0	N/A	N/A
5	Normal	26	M	19	17	0	N/A	N/A
6	Normal	56	F	22	21	0	N/A	N/A
7	NASH	55	M	78	43	4	1a	N/A
8	NASH	45	F	30	92	5	3	N/A
9	NASH	61	F	54	89	4	2	N/A
10	NASH	41	M	81	x	4	x	N/A
11	NASH	43	M	x	x	4	1a	N/A
12	NASH	35	M	x	x	4	1b	N/A
13	NASH	27	M	78	x	4	2	N/A
14	NASH	69	M	x	x	4	3	N/A
15	NASH	39	F	69	350	5	1b	N/A
16	NASH	54	F	130	110	4	2	N/A
17	NASH	59	M	228	329	6	4	N/A
18	NASH	49	M	x	x	5	2	N/A
19	NASH	27	F	x	x	5	2	N/A
20	NASH	44	M	84	42	5	1b	N/A
21	NASH	64	F	60	43	4	2	N/A
22	NASH	50	F	x	x	4	1a	N/A
23	ASH	63	F	40	115	4	N/A	N/A
24	ASH	51	M	x	x	2	N/A	N/A
25	ASH	75	F	x	x	3	N/A	N/A
26	ASH	46	M	50	160	4	N/A	N/A
27	ASH	58	M	105	x	4	N/A	N/A
28	ASH	70	M	x	x	1	N/A	N/A
29	ASH	43	M	380	170	0	N/A	N/A
30	ASH	64	M	x	x	3	N/A	N/A
31	HBV	19	M	234	86	1	N/A	2
32	HBV	60	M	115	86	3	N/A	1
33	HBV	41	F	76	52	1	N/A	2
34	HBV	27	F	71	41	1	N/A	2
35	HBV	48	F	x	x	1	N/A	1
36	HBV	77	M	63	137	1	N/A	1
37	HCV	54	F	44	38	3	N/A	2
38	HCV	50	M	102	85	1	N/A	1
39	HCV	58	M	66	x	2	N/A	1
40	HCV	57	F	215	164	3	N/A	1
41	HCV	55	M	135	129	2	N/A	2
42	HCV	73	F	93	81	3	N/A	1
43	HCV	71	F	x	x	4	N/A	2
44	HCV	60	F	20	40	4	N/A	2
45	HCV	70	F	242	215	4	N/A	2
46	HCV	57	F	93	51	2	N/A	2

Fibrosis grade was analyzed for NASH according to NAS (NAFLD activity score) and for others according to METAVIR score. Disease activity of viral hepatitis was analyzed according to METAVIR score. x: not available, N/A: not applicable.